Varian的封面图片
Varian

Varian

医疗设备

Palo Alto,CA 301,675 位关注者

At Varian, a Siemens Healthineers company, we envision a world without fear of cancer.

关于我们

At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy, to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. Varian reserves the right to remove any comment for any reason and ban any user from its page at its sole discretion. Varian does not endorse user comments on its page and cannot confirm their accuracy. User comments do not necessarily represent the ideas, thoughts, beliefs, opinions or views of Varian, or any of its affiliates.

网站
https://www.varian.com
所属行业
医疗设备
规模
5,001-10,000 人
总部
Palo Alto,CA
类型
上市公司

地点

  • 主要

    Varian Medical Systems, Inc.

    3100 Hansen Way

    US,CA,Palo Alto,94304-1030

    获取路线

Varian员工

动态

  • 查看Varian的组织主页

    301,675 位关注者

    Varian is excited to announce a U.S. co-marketing and sales agreement with Embolx for the sale and market development of the Sniper Balloon Occlusion Microcatheter. Read the press release: https://bit.ly/3Y6kJ9a ? Sniper utilizes a pressure-directed balloon system for occlusion, altering blood flow-dynamics and controlling local blood pressure to precisely deliver embolic agents into target areas, effectively starving a tumor of blood supply while protecting surrounding healthy tissues. ? Want to learn more? Visit us at #SIR25NASH to go hands on with Sniper.

  • 查看Varian的组织主页

    301,675 位关注者

    A recent study took a novel approach in evaluating image quality across multiple institutions using the HyperSight imaging solution, helping to ensure consistent imaging performance across various clinical environments.? ? ?? Multi-institutional collaboration? ? 2 traveling phantoms – evaluated across multiple sites? ?? 6 institutions? ? 3 Halcyon/3 Ethos radiotherapy platforms? ?? 1 impactful publication? ? By sending just two standardized phantoms to different facilities, this research effectively assessed the reproducibility and reliability of CBCT imaging in diverse clinical scenarios.? ? Read the full study here: https://bit.ly/3Y9mYsn? Learn more about HyperSight: https://bit.ly/443myrh QR700020863?

  • 查看Varian的组织主页

    301,675 位关注者

    A decade ago, cancer care in Brazil faced?significant gaps in both radiotherapy capacity and modern treatment capability. This forced patients to?travel long distances and contend with extreme wait times to begin treatment. ? Today, the country is equipped with a large fleet of C-series linear accelerators thanks to a decade long partnership between Varian and the Brazilian Ministry of Health, slashing both wait times and the average distance patients must travel to receive radiotherapy for their cancer diagnosis. While there is still much work to be done to bridge the gap between rising cancer diagnoses and the current care infrastructure,?we are extremely proud to have been part of such a transformational project to expand access to care for the world's fifth largest country.?https://bit.ly/4cleCnD QR700018943

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
  • 查看Varian的组织主页

    301,675 位关注者

    One oncology provider stepped up their clinical ops with the InSightive Gen2 solution, creating dashboards used daily by their entire team – from clinicians to leadership.? ? The differentiator? Native integration between InSightive Gen2 and ARIA CORE, Varian's oncology management solution. Seamless data flow turns their workflow investment into actionable insights that enhance patient care.?

  • 查看Varian的组织主页

    301,675 位关注者

    Varian's RapidArc Dynamic* solution aims to address one of the biggest challenges in breast cancer radiotherapy: balancing tumor control while minimizing toxicity. A recent study from the Penn Medicine, University of Pennsylvania Health System highlights a promising approach — using a single-arc, two-modulated port plan. In a 13-patient cohort, this technique significantly reduced heart and lung doses compared to conventional two-arc VMAT plans, aligning with ASTRO’s guidelines for minimizing heart exposure. While more research is needed, these findings point to an exciting step forward for organ-sparing. Read the full abstract: https://bit.ly/4iIATxr Request more information on RapidArc Dynamic: https://bit.ly/437eXHI *RapidArc Dynamic is an optional feature. The statement by Varian’s customer described here is based on results achieved in the customer’s unique clinical setting. Because there is no “typical” clinical setting and many variables exist, there is no guarantee that other customers will achieve the same results. QR700020245

    • 该图片无替代文字
    • 该图片无替代文字
  • 查看Varian的组织主页

    301,675 位关注者

    “At Varian we’re always looking for ways to streamline our processes to deliver more value to our customers,” says Kevin Mace, Head of Global Installations for Varian. ? “That's why we're excited to introduce a new digital documentation tool to streamline the installation and upgrade process for MedTech systems. By improving efficiency and traceability, the new process allows our engineers to focus on installing our equipment rather than chasing paperwork.”? Learn more at: https://bit.ly/3Rikjc1 QR700020247

相似主页

查看职位